Is a whole-body MRI (Prenuvo) or a Neko Health body scan worth it for a healthy person?

If you feel fine and your risk is average, there is no good evidence that a whole-body MRI helps you live longer. That is not because a big trial tested it and came up empty. As of October 2026, no randomized trial has tested whether whole-body MRI screening lowers deaths.^{[26, 8]} Such a trial would split people by chance into a scanned and an unscanned group and compare what happens. Without one, the promised benefit is untested rather than disproven.

Prenuvo and Neko Health both sell a check-up to people who feel fine, but they sell different things. Prenuvo, a US company, offers a whole-body MRI and opened its first European clinic in London in November 2025.^[14] Neko Health, the Swedish company co-founded by Spotify's Daniel Ek, offers a body scan with more than 70 sensors plus blood tests instead.^[24] It launched in London at GBP 299 in 2024 and is not an MRI at all.^[24] German radiology practices sell their own whole-body MRI too, and side by side the three options differ far more in method and price than in evidence:

Sources: Prenuvo^[14] Neko launch coverage,^[24] one German practice's price list,^[22] FDA,^[20] evidence reviews.^{[26, 8]}

For Neko we found no trial showing a health benefit either, and since it is not an MRI, the MRI figures below do not apply to it. Those figures come from studies that count findings, not saved lives. A 2019 review of those studies found that none had checked, over more than five years, whether clean results were truly clean.^[1] A 2026 review goes further and calls scanning healthy people for many diseases at once a major break with the basic rules of screening.^[6]

What those studies count is mostly not cancer. A 2025 analysis that pooled earlier studies of people without symptoms found cancer in about 1.6% of those scanned.^[2] Most of the pooled studies had a moderate to serious risk of bias, meaning design flaws that can skew their results.^[2] That small signal sits under a much larger pile of incidental findings, the things a scan spots that have nothing to do with why you came.

So the trade is simple to state, if less simple to buy. You pay for a small chance of catching a real cancer, and alongside it you are likely to get findings that send you for more tests. A clean scan can still miss small cancers and cancers in the lungs or bowel,^[18] which makes the peace of mind thinner than the price suggests.

A whole-body MRI is strongest in solid organs and weakest in the lungs and bowel. It pictures soft tissue well, so it can find solid tumours from about a centimetre across in organs it images clearly, such as the kidney or liver.^[18] The studies also list aneurysms, bulging weak spots in a blood vessel wall, among its findings.^[1] That is a real strength, but it comes with a limit that is easy to overlook: a normal scan cannot rule a tumour out.^[18]

Prenuvo's own disclaimer spells out where the gaps are. It says the scan may miss very small cancers, does not assess small lung nodules and is limited for the bowel.^[18] The same page says the scan does not replace colonoscopy, breast imaging, the Pap test or low-dose lung CT for high-risk people.^[18] A clean result can therefore give you false comfort, above all about lung and bowel cancer.

Those gaps make the scan extra imaging at best, on top of the screening you already qualify for. It does not cancel your mammogram, bowel screening or cervical screening. If lung cancer is your worry, the test with evidence is a low-dose CT, which German statutory insurance now pays for long-term heavy smokers aged 50 to 75.^[21]

On safety, MRI has one clear advantage over a CT or a coronary calcium (CAC) scan: it uses no ionizing radiation.^[20] It is not risk-free for everyone, though, because the strong magnet can pull metal objects and disturb implanted devices.^[20] Before you book, tell the practice about any pacemaker, pump, stimulator, cochlear implant, metal fragment or clip. A device is only scanned if it is confirmed MRI-safe or MRI-conditional (safe only under specific conditions the scanning team must check).^[20] Prenuvo does not scan people with pacemakers and does not do screening scans in pregnancy.^[19]

The scanner is also loud, so you get ear protection. Skin burns are rare, but they are the most commonly reported injury.^[20] Once that safety check is done, the hour in the scanner is the low-risk part. For most healthy people the more common problem starts afterwards, when the scan finds something.

Almost every whole-body MRI finds something, and in people without symptoms the radiologist sees at least one abnormality in 19 of every 20 scans.^[12] How many of these you are told about depends on the practice.^[12] Most are harmless: about 91% of all findings are benign.^[12] Even so, about 3 in 10 people get a finding that needs more tests, while cancer is suspected in fewer than 2 in 100.^[12]

Those totals include every harmless finding, so the numbers that matter for follow-up come from a narrower count. In the 2019 review, about a third of scans showed a critical or unclear finding, the kind a radiologist wants to look at again.^[1] Where studies reported false alarms, findings that later proved harmless, they made up about 1 in 6 of those findings, though this pooled estimate is very uncertain.^[1] Only about 1 in 8 of these findings had a reported follow-up check, so the true false-alarm rate remains unknown.^[1]

The German SHIP research study shows what that follow-up looks like in practice. Of the 3,371 people who had a whole-body MRI there, about 3 in 10 were told about an incidental finding, most of them possible tumours.^[3] Biopsies went up after people were told about their findings, and most biopsies in the study found no cancer or tumour.^[3]

Those negative biopsies need careful reading. The study could not link each biopsy to a specific finding.^[3] A negative biopsy is also not the same as overdiagnosis, which means finding disease that would never have caused trouble. Still, the results show how often follow-up testing ends in needles and tissue samples that find nothing. The authors call this overtesting and ask for stricter rules on which findings research studies disclose.^[3]

In everyday terms, one finding can lead to more MRIs, blood tests, specialist visits and sometimes a biopsy with its own small risk of complications. Much of that work-up ends without finding anything that needs treatment. For the roughly 3 in 10 people whose scan needs a closer look, extra tests, lost time and worry are part of the deal.^[12]

The major radiology societies do not recommend whole-body MRI screening for people at average risk who feel fine. The American College of Radiology (ACR) found in 2023 that there is not enough evidence to recommend it for people without symptoms, risk factors or family history.^[11] It also found no documented evidence that the scan saves money or helps people live longer.^[11] A 2019 review goes one step further and says providers should not offer it to healthy people outside a research setting.^[1]

RANZCR, the radiology college of Australia and New Zealand, agrees in its 2025 position statement.^[8] A 2026 expert panel adds that the practice is spreading although no guideline endorses it.^[26] For Germany we could not find a clear position on self-pay whole-body MRI from the national radiology society, the Deutsche Röntgengesellschaft (DRG). This guide therefore relies on the international statements.

Behind those verdicts sit the harms the findings data already show. Reviews name false positives, meaning false alarms, and incidentalomas, unexpected lumps the scan stumbles on that are mostly harmless.^{[12, 6]} They also name overdiagnosis, disease found that would never have caused trouble, and the lack of any proven gain in lifespan.^{[12, 6]} The 2026 panel adds substantial direct and downstream costs and calls for trials of benefit and cost-effectiveness.^[26]

Studies on psychological harm point both ways. In the SHIP study, about 3 in 10 people told about a finding reported moderate to severe distress afterwards.^[17] A small Italian study, in which most people had low-grade findings, saw only a slight rise in depressive symptoms a year later.^[7] Its group shrank sharply by year four, so it is weak evidence either way.^[7] Later surveys found no lasting difference in quality of life,^[12] which points to a real but passing cost rather than lasting damage.

A test that flags about a third of people for a second look without being shown to lower deaths is hard to recommend to someone who feels well.^[1] Every one of these verdicts is aimed at people like that, without symptoms or a known high risk. RANZCR's statement explicitly leaves out people who have had cancer or carry a cancer predisposition syndrome,^[8] and for that group the case looks different.

The one group with a clear case for whole-body MRI is small: people born with a high-risk cancer syndrome, above all Li-Fraumeni syndrome. It is caused by a harmful change in the TP53 gene, whose normal job is to stop cells from turning cancerous. You are born with that change, which is usually inherited.^[25] In about 7 to 20% of people it arises new, though, so a missing family history does not rule it out.^[25] Carriers face a very high lifetime cancer risk, and expert recommendations for them include a yearly whole-body MRI as part of a wider surveillance programme.^[16]

In carriers, the same scan finds far more. A pooled analysis of earlier studies found cancer in about 6% of carriers on their first scan.^[4] Most of those cancers, 41 of 46, were caught at an early stage.^[4] Other pooled analyses, drawing on largely the same studies, came to about 7%.^{[5, 10]} Next to the roughly 1.6% in average-risk people, that is about four times the yield, though only as a rough comparison across different studies.^[2]

Whether finding those cancers early helps carriers live longer has some support, though weaker than the headline numbers suggest. The evidence comes from one small observational study, which watched what happened rather than assigning people to groups.^[15] Among carriers who developed cancer, 5-year survival after diagnosis was about 89% when a broad surveillance programme found the tumour and about 60% when symptoms did.^[15] Whole-body MRI was only one part of that programme, and people chose their group and could switch. Earlier diagnosis alone also makes survival look longer, so the gap overstates what MRI itself does.^[15]

The difference between carriers and everyone else comes down to the odds going in, not to anything special about the machine. In a group where cancer really is common, the same test finds far more real cancers, most of them early. Even there, fewer than 1 in 5 suspicious spots turn out to be cancer.^[4]

Real symptoms are a different matter. If you have a lump, pain that will not go away or bleeding, a screening scan is the wrong tool, because you need a targeted work-up through a doctor.

If you do carry a TP53 change or a similar high-risk syndrome, surveillance is a medical decision for you and a genetics or oncology team. It is not a self-pay scan you book online, so ask that team to request cost approval from your insurer before the first scan.

Without a medical reason such as a cancer syndrome, a basic whole-body MRI at a German radiology practice starts at about 1,000 EUR (as of October 2026).^[22] Practices bill it privately under the GOÄ, Germany's official fee schedule for private medical bills.^[22] At one practice, for example, 999 EUR covers head, spine, chest, abdomen and pelvis.^[22] Add-ons such as vessels, heart, prostate or breast cost extra, and contrast agent or a higher fee rate can add more.^[22] Prenuvo's London clinic sits well above that at about GBP 2,499 (as of October 2026).^[14]

Who pays is mostly you. German statutory insurance does not pay for a screening whole-body MRI, so practices bill it as a self-pay service, known in German as IGeL.^[22] Swiss basic insurance does not list it among the screenings it covers either.^[23] Whether private insurance pays depends on your tariff, so get written confirmation before you book. In Switzerland some supplementary plans pay part of it.^[23] KPT, for example, reimburses 75% of a whole-body MRI at named providers under certain Pulse plans (as of October 2026).^[23]

The scan price is not the whole cost, either. A finding can lead to follow-up scans, specialist visits and biopsies, which cost time and add to health spending.^[26] A 2026 expert panel counts these downstream costs as a main drawback.^[26] In the SHIP study, biopsies went up after findings were disclosed, and each one carries its own small risk of complications.^[3]

Then there is your data. A whole-body image is sensitive health data, and a check that adds blood results, as Neko's does, adds more.^[24] The studies on the scan say nothing about how providers handle it. Under GDPR, Europe's data-protection law, these are fair questions to ask before you book:

• Where are the images and any AI analysis stored and processed, on EU or US servers?
• What exactly are you consenting to?
• How long are the data kept?
• Who can access them?

For an average-risk adult, the same money probably does more elsewhere. A reasonable order is to finish the breast, bowel and cervical screening you qualify for first. German statutory insurance has also paid for a yearly low-dose CT lung scan since April 2026 (as of October 2026).^[21] It covers current and former heavy smokers aged 50 to 75, where heavy means at least 25 years of smoking without long breaks and at least 15 pack-years.^[21] One pack-year means a pack a day for a year. A family doctor or internist checks whether you qualify, and if you quit ten or more years ago, you usually no longer do.^{[21, 27]}

Beyond that, add blood markers that have evidence behind them. Leave whole-body MRI to people with a high-risk syndrome or a research study, where the evidence for it actually lives. If you still want the scan, ask before booking what the quoted price covers and what follow-up tests would cost you if it finds something.